Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Lpath, Inc. (LPTN) Starts Presentation at 25th Annual ROTH Conference

Posted on March 19, 2013 by Mission IR

Lpath is a therapeutic antibody company and an industry leader in lipid-targeted therapeutics. ImmuneY2, the company’s drug-discovery engine, has the singular ability to generate monoclonal antibodies that bind to and inhibit bioactive lipids, which contribute to disease. Based in San Diego, Calif., the company has three drug candidates currently in development: iSONEP, ASONEP and Lpathomab. For more information, visit the company’s Web site: http://www.Lpath.com

Let us hear your thoughts below:

This year's annual ROTH Conference will take place at The Ritz Carlton located in Laguna Niguel, on March 17-12, 2013. Bringing together executives from more than 400 growth companies, the ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com.
This entry was posted in ROTH Capital Partners Conference. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *